NO20085067L - 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter - Google Patents
4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenterInfo
- Publication number
- NO20085067L NO20085067L NO20085067A NO20085067A NO20085067L NO 20085067 L NO20085067 L NO 20085067L NO 20085067 A NO20085067 A NO 20085067A NO 20085067 A NO20085067 A NO 20085067A NO 20085067 L NO20085067 L NO 20085067L
- Authority
- NO
- Norway
- Prior art keywords
- diphenyl
- carboxylic acids
- medicaments
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006021873 | 2006-05-11 | ||
PCT/EP2007/003805 WO2007131621A1 (de) | 2006-05-11 | 2007-04-30 | 4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085067L true NO20085067L (no) | 2009-02-06 |
Family
ID=38370354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085067A NO20085067L (no) | 2006-05-11 | 2008-12-04 | 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter |
Country Status (17)
Country | Link |
---|---|
US (1) | US7709490B2 (zh) |
EP (1) | EP2024338B1 (zh) |
JP (1) | JP2009536628A (zh) |
KR (1) | KR20090006847A (zh) |
CN (1) | CN101421248A (zh) |
AR (1) | AR060991A1 (zh) |
AT (1) | ATE441638T1 (zh) |
AU (1) | AU2007250212A1 (zh) |
BR (1) | BRPI0711416A2 (zh) |
CA (1) | CA2651658A1 (zh) |
DE (1) | DE502007001453D1 (zh) |
IL (1) | IL195176A0 (zh) |
MX (1) | MX2008014204A (zh) |
NO (1) | NO20085067L (zh) |
TW (1) | TW200817339A (zh) |
UY (1) | UY30337A1 (zh) |
WO (1) | WO2007131621A1 (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ES2428288T3 (es) * | 2009-05-12 | 2013-11-06 | Actelion Pharmaceuticals Ltd. | Novedosos derivados de oxazolidinona y su uso como antagonistas del receptor de la orexina |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP3159331A1 (en) | 2010-05-05 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
US8450350B2 (en) | 2010-05-05 | 2013-05-28 | Infinity Pharmaceuticals, Inc. | Triazoles as inhibitors of fatty acid synthase |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
US20130197043A1 (en) | 2010-08-31 | 2013-08-01 | Snu R&Db Foundation | Use of the fetal reprogramming of a ppar agonist |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN105142621A (zh) | 2012-10-24 | 2015-12-09 | 国家健康科学研究所 | 用于预防或治疗糖尿病和促进β-细胞存活的TPL2激酶抑制剂 |
EP3076959B1 (en) | 2013-12-04 | 2018-07-04 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
WO2015119899A1 (en) | 2014-02-06 | 2015-08-13 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
ES2805743T3 (es) | 2015-03-24 | 2021-02-15 | Inst Nat Sante Rech Med | Método y composición farmacéutica para uso en el tratamiento de la diabetes |
CN106279041A (zh) * | 2016-08-16 | 2017-01-04 | 四川思睿博生物科技有限公司 | 苯基嘧啶衍生物及其制备方法和用途 |
PL3752501T3 (pl) | 2018-02-13 | 2023-08-21 | Gilead Sciences, Inc. | Inhibitory pd-1/pd-l1 |
JP7242702B2 (ja) | 2018-04-19 | 2023-03-20 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
KR20230159715A (ko) | 2018-07-13 | 2023-11-21 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
KR102635333B1 (ko) | 2018-10-24 | 2024-02-15 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100613175B1 (ko) * | 1998-08-27 | 2006-08-17 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제 |
US6696474B2 (en) * | 2002-04-03 | 2004-02-24 | Warner Lambert Co. Llc. | Antidiabetic agents |
-
2007
- 2007-04-30 BR BRPI0711416-8A patent/BRPI0711416A2/pt not_active IP Right Cessation
- 2007-04-30 CA CA002651658A patent/CA2651658A1/en not_active Abandoned
- 2007-04-30 MX MX2008014204A patent/MX2008014204A/es not_active Application Discontinuation
- 2007-04-30 AT AT07724732T patent/ATE441638T1/de active
- 2007-04-30 DE DE502007001453T patent/DE502007001453D1/de active Active
- 2007-04-30 WO PCT/EP2007/003805 patent/WO2007131621A1/de active Application Filing
- 2007-04-30 EP EP07724732A patent/EP2024338B1/de not_active Not-in-force
- 2007-04-30 JP JP2009508192A patent/JP2009536628A/ja not_active Withdrawn
- 2007-04-30 CN CNA2007800131434A patent/CN101421248A/zh active Pending
- 2007-04-30 AU AU2007250212A patent/AU2007250212A1/en not_active Abandoned
- 2007-04-30 KR KR1020087027645A patent/KR20090006847A/ko not_active Application Discontinuation
- 2007-05-09 AR ARP070102009A patent/AR060991A1/es unknown
- 2007-05-09 TW TW096116361A patent/TW200817339A/zh unknown
- 2007-05-10 UY UY30337A patent/UY30337A1/es not_active Application Discontinuation
-
2008
- 2008-11-09 IL IL195176A patent/IL195176A0/en unknown
- 2008-11-10 US US12/267,912 patent/US7709490B2/en not_active Expired - Fee Related
- 2008-12-04 NO NO20085067A patent/NO20085067L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE502007001453D1 (de) | 2009-10-15 |
AU2007250212A1 (en) | 2007-11-22 |
UY30337A1 (es) | 2008-01-02 |
EP2024338A1 (de) | 2009-02-18 |
TW200817339A (en) | 2008-04-16 |
WO2007131621A1 (de) | 2007-11-22 |
BRPI0711416A2 (pt) | 2011-11-01 |
JP2009536628A (ja) | 2009-10-15 |
AR060991A1 (es) | 2008-07-30 |
CA2651658A1 (en) | 2007-11-22 |
KR20090006847A (ko) | 2009-01-15 |
US7709490B2 (en) | 2010-05-04 |
US20090149477A1 (en) | 2009-06-11 |
MX2008014204A (es) | 2008-11-14 |
ATE441638T1 (de) | 2009-09-15 |
EP2024338B1 (de) | 2009-09-02 |
CN101421248A (zh) | 2009-04-29 |
IL195176A0 (en) | 2009-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085067L (no) | 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
NO20085066L (no) | 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
NO20085064L (no) | 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
NO20056010L (no) | Biaryloksymetylaren-karboksylsyrer | |
NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
NO20083514L (no) | Heterobicykliske sulfonamidderivater for behandling av diabetes | |
NO20092476L (no) | Antibakterielle polycykliske ureaforbindelser | |
WO2008055870A8 (en) | Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture | |
WO2008034859A8 (en) | Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | |
WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
NO20092033L (no) | Nye forbindelser | |
TW200635878A (en) | Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use | |
NO20070176L (no) | Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav | |
ZA200802454B (en) | Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
WO2010003624A3 (en) | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof | |
NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
NO20084177L (no) | Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler | |
NO20083441L (no) | Benzoisoindolderivater for behandling av smerte | |
NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |